Clin2
NCT07130396Possibly a fitNot yet recruiting

Multivitamin and probiotic for gut health on GLP-1 medication

GLP-1Adults

Part of Digestive system clinical trials.

This trial tests whether taking a multivitamin and a probiotic together can improve gut health for people who are currently taking a GLP-1 medication (like Ozempic or Wegovy). It aims to see if these supplements help with digestive issues that can come with these medications.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been taking a GLP-1 medication (like Ozempic, Wegovy, or Mounjaro) for at least 4 weeks and no longer than 1 year.
  • Your body mass index (BMI) is between 25 and 30.
  • You are willing to keep your diet and exercise habits the same during the study.
  • You are willing to avoid starting any new supplements during the study (except those you've been taking consistently for 2 weeks before, but no probiotics).
  • You have not had bariatric surgery, do not have severe chronic diseases (like cancer, HIV, type 1 diabetes, or inflammatory bowel disease), and are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07209046Not yet recruiting
Probiotic support after stopping weight-loss medication

This trial tests whether a daily probiotic supplement can help people maintain their weight after they stop taking a GLP-1 medication (like Ozempic or Wegovy). It aims to see if the probiotic helps keep the weight off.

NCT07437911Recruiting
Can a Supplement Help with Nutrient Gaps for GLP-1 Users?

This study tests whether a daily supplement can help fill nutrient gaps and improve gut health for people who are already taking GLP-1 weight-loss medications (like Ozempic or Wegovy). Participants must be on a stable dose for at least 8 weeks and be generally healthy without other chronic conditions.

Santa Monica, California
NCT07234916Enrolling by invitation
Multivitamins for people starting weight-loss injections

This trial tests whether a multivitamin can help people on the weight-loss injection Tirzepatide maintain healthy vitamin levels. If you're using this injection and meet the other criteria, you may join.

Amersfoort
NCT07089732Not yet recruiting
GLP-1 drink for blood sugar and gut health

This trial tests a special drink that may help improve blood sugar levels and gut health in people with prediabetes. It could offer a simple way to manage blood sugar and potentially prevent diabetes.

Taichung, South
NCT07457723Recruiting· Phase 2
Gut health and metabolism study

This study tests whether a supplement can improve metabolic health by changing the bacteria in your gut. It looks at how your body processes food and energy.

Brisbane, Queensland
NCT07784127Not yet recruiting
How GLP-1 medicines affect stomach and bowel movement

This study will look at how medicines like Ozempic, Wegovy, and Mounjaro affect how well the stomach and intestines move food through the body. It might help find out why these medicines cause digestive problems for some people.

Cleveland, Ohio

Hear when a new GLP-1 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.